NVTA INVITAE CORP

Invitae to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company’s management team will present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 17, 2016 at approximately 3:00 p.m. Eastern at the Westin Grand Central in New York City.

The live, listen-only webcast of the presentation may be accessed by visiting the investors section of the company’s website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the company’s website.

About Invitae

Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. For more information, visit our website at invitae.com.

EN
17/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INVITAE CORP

An unfavourable environment weighs on INVITAE, which sees a downgrade ...

The independent financial analyst theScreener just requalified the general evaluation of INVITAE (US), active in the Biotechnology industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Negative. As of the analysis date January 14, 2022, the closing price was USD 11.74 ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Invitae Corp: 2 directors gave away/sold

Two Directors at Invitae Corp gave away/sold 320,597 shares at between 0.000USD and 48.618USD. The significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch